La texture leggera e facilmente stratificabile lo rende adatto a routine skincare quotidiane, anche su pelli sensibili o disidratate
In a head-to-head open-label trial reported in February 2026, average weight loss at 84 weeks favored tirzepatide, and the sponsor noted CagriSema did not meet its prespecified non-inferiority target against tirzepatide
J Clin Endocrinol Metab 95:24862491 [DOI] [PMC free article] [PubMed] [Google Scholar] Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations
A consultation will determine the best plan for you.